Abstract
Antipsychotics represent high affinity for sigma receptors and sigma-like drugs often have the psychotomimetic properties. Besides, the receptors are unevenly distributed in human brain. These findings suggest that sigma receptors might be involved in the pathophysiology of schizophrenia. Sigma receptors in rat and human brain were measured with [3H]-1, 3, di-o-tolylguanidine (DTG) and non-specific binding of [3H]DTG was determined in the presence of 10−5M haloperidol. Monovalent and divalent cations strongly inhibited [3H]DTG binding. Glutamate, aspartate and glycine also decreased the binding to human cerebral membranes. With post-mortem brain samples from 12 schizophrenics and 10 controls, sigma receptors were measured in 17 areas of cerebral cortex. Sigma receptors binding showed the regional differences in the cortex, but no significant differences between schizophrenics and controls were observed except the superior parietal cortex where the binding significantly increased in the schizophrenic group. These results suggest that sigma receptors in cerebral cortices might not be directly concerned with the pathophysiological role in schizophrenia.
Similar content being viewed by others
References
Haertzen C. A. 1970. Subjective effects of narcotic antagonists cyclazocine and nalorphine on the addiction research center inventory (ARCI). Psychopharmacology, 18:366–377.
Martin, W.R., Eades, C.G., Thompson, J.A., Huppler, R.E., and Gilbert, P.E. 1976. The effect of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:517–532.
Brady, K.T., Balster, B.L., and May, E.I. 1982. Stereoisomers of N-allylnormetazocine: Phencyclidine-like behavioral effects in squirrel monkey and rats. Science, 215:178–180.
Zukin, R.S., and Zukin, S.R. 1981. Demonstration of3H-cyclazocine binding to multiple opiate receptor sites. Mol. Pharmacol. 20:246–254.
Sonders, M.S., Keana, J.F.W., and Weber, E. 1988. Phencyclidine and psychotomimetic sigma opiates: Recent insights into their biochemical and physiological sites of action. TINS, 11:37–40.
Tam, S.W., Steinfels, G.F., and Cook, L. 1988. Biochemical and behavioral aspects of sigma and phencyclidine receptors: Similarities and differences. Pages 383–396,in Domino, E.F. and Kamenka, J.-M. (eds) Sigma and Phencyclidine-Like Compounds as Molecular Probes in Biology. NPP Books, Ann Arbor, MI.
Su, T.-P. 1982. Evidence for sigma opioid receptor: Binding of [3H]SKF-10,047 to etorphine-inaccessible sites in guinea pig brain. J. Pharmacol. Exp. Ther. 223:284–290.
Tam, S.W. 1983. Naloxone-inaccessible sigma receptor in rat central nervous system. Proc. Natl. Acad. Sci. USA. 80:6703–6707.
Martin, B.R., Katzen, J.S., Woods, J.S., Tripathi, H.L., Harris, L.S. and May, E.L. 1984. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. J. Pharmacol. Exp. Ther. 231:539–544.
Gundlach, A.L., Largent, B.L., and Snyder, S.H. 1985. Phencyclidine and sigma opiate receptors in brain: Biochemical and autoradiographical differentiation. Eur. J. Pharmacol. 113:456–466.
Gundlach, A.L., Largent, B.L., and Snyder, S.H. 1986. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci. 6:1757–1770.
Largent, B.L., Gundlach, A.L., and Snyder, S.H. 1986. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,046, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238:739–745.
Weber, E., Sonders, M., Quarum, M., McLean, S., Pou, S., and Keana, J.F.W. 1986. 1,3-Di(2-[5-3H]tolyl)guanidine: A selective ligand that label sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc. Natl. Acad. Sci. USA 83:8784–8788.
Tam, S.W., and Cook, L. 1984. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]-haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA. 81:5618–5621.
Itzhak, Y. 1988. Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites. Life Sci., 42:745–752.
Largent, B., Wikstrom, H., Snowman, A. M., and Snyder, S.H. 1988. Novel antipsychotic drugs share high affinity of sigma receptors. Eur. J. Pharmacol. 155:345–347.
Weissman, A.D., Casanova, D.E., Kleinman, J.E., London, E.D., and De Souza, E.B. 1991. Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry. 29:51–54.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 259:265–275.
Contreras, P.C., Contreras, M.L., Compton, R.P., and O'Donohue, T.L. 1988. Biochemical and behavioral characterization of PCP and sigma receptors. Pages 327–343,in Domino, E.F. and Kamenka, J.-M. (eds) Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology. NPP Books, Ann Arbor, MI.
Contreras, P.C., Contreras, M.L., O'Donohue, T.L. and Lair, C.C. 1988. Biochemical and behavioral effects of sigma and PCP ligands. Synapse 2:240–243.
Largent, B.L., Gundlach, A.L., and Snyder, S.H. 1984. Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-3(3-hydroxyphenyl)-N-(1-propyl)piperidine. Neurobiology, 81:4983–4987.
Schwarz, S., Zhou, G-Z, Katki, A.G., and Rodbard, D. 1990. Differential modulation by cations of sigma and phencyclidine binding sites in rat brain. J. Receptor Research. 10:11–27.
Loo, P., Braunwalder, A., Lehmann, J., and Williams, M. 1986. Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists. Eur. J. Pharmacol. 123:467–468.
Johnson, K.M., Sacaan, A.I., and Snell, L.D. 1988. Equilibrium analysis of (3H)TCP binding: effects of glycine, magnesium and N-methyl-D-aspartate agonists. Eur. J. Pharmacol. 152:141–146.
Itzhak, Y. 1989. Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: effect of N-methyl-D-aspartate agonists and antagonists. Neuroscience Letters. 104:314–319.
Perry, T.L., Berry, K., Hansen, S., Diamond, S., and Mok, C. 1971. Regional distribution of amino acids in human brain obtained at autopsy. J. Neurochem. 18:513–519.
Perry, T.L., Hansen, S., and Kennedy, J. 1975. CSF amino acids and plasma-CSF amino acid ratios in adults. J. Neurochem. 24: 587–589.
McLean, S., and Weber, E. 1988. Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea pig brains. Neuroscience, 25:259–269.
Weissman, A.D., Su, T.-P., Hedreen, J.C., and London, E.D. 1988. Sigma receptor in post-mortem human brain. J. Pharmacol. Exp. Ther. 247:29–33.
Toru, M., Watanabe, S., Shibuya, H., Nishikawa, T., Noda, K., Mitsushio, H., Ichikawa, H., Kurumaji, A., Takashima, M., Mataga, N., and Ogawa, A. 1988. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr. Scand. 78:121–137.
Suga, I., Kobayashi, T., Ogata, H., and Toru, M. 1990. Increased3H-MK 801 binding sites in post-mortem brains of chronic schizophrenic patients. 17th CINP Abstracts Page 274.
Kiuchi, Y., Kobayashi, T., Takeuchi, J., Shimizu, H., Ogata, H., and Toru, M. 1989. Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics. Eur. Arch. Psychiatr. Neurol. Sci. 23:71–78.
Author information
Authors and Affiliations
Additional information
Dedicated to Dr. Morris Aprison. Received too late for publication in special issue.
Rights and permissions
About this article
Cite this article
Shibuya, H., Mori, H. & Toru, M. Sigma receptors in schizophrenic cerebral cortices. Neurochem Res 17, 983–990 (1992). https://doi.org/10.1007/BF00966825
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00966825